Mark A. Emalfarb is the founder of Dyadic, a global biotechnology company focusing on the discovery, development, and manufacturing of novel products derived from the DNA of complex living organisms. He has been a member of the company’s board of directors since October 2004 and has served as its Chairman as well as President and Chief Executive Officer from October 2004 until April 2007 and from June 2008 until the present.
